Hoge Stephen

President · SEC CIK 1760669
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$28.45M
25 trades
Net flow
−$28.45M
Net selling
Total filings
84
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Jun 4, 2024

Hoge Stephen sold $47.7K of MRNA.

−$47.7K
339 sh @ $141
MRNA
Sell Hoge Stephen · President · Open-market sale · filed May 30, 2024

Hoge Stephen sold $49.3K of MRNA.

−$49.3K
341 sh @ $145
MRNA
Sell Hoge Stephen · President · Open-market sale · filed May 17, 2024 ΔOwn −1.0%

Hoge Stephen sold $1.91M of MRNA, trimming their stake 1%.

−$1.91M
15,000 sh @ $127
Advertisement
MRNA
Sell Hoge Stephen · President · Open-market sale · filed May 13, 2024

Hoge Stephen sold $30.8K of MRNA.

−$30.8K
255 sh @ $121
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Apr 16, 2024 ΔOwn −1.0%

Hoge Stephen sold $1.58M of MRNA, trimming their stake 1%.

−$1.58M
15,000 sh @ $105
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Mar 19, 2024 ΔOwn −1.0%

Hoge Stephen sold $1.55M of MRNA, trimming their stake 1%.

−$1.55M
15,000 sh @ $103
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Mar 5, 2024

Hoge Stephen sold $29.2K of MRNA.

−$29.2K
309 sh @ $94
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Mar 1, 2024 ΔOwn −0.2%

Hoge Stephen sold $225.8K of MRNA.

−$225.8K
2,388 sh @ $95
MRNA
Option exercise Hoge Stephen · President · Option exercise · filed Mar 1, 2024 ΔOwn +0.2%
+$0
2,442 sh
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Feb 23, 2024 ΔOwn −1.0%

Hoge Stephen sold $1.5M of MRNA, trimming their stake 1%.

−$1.5M
15,000 sh @ $100
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Feb 16, 2024 ΔOwn −0.7%

Hoge Stephen sold $937K of MRNA, trimming their stake 1%.

−$937K
10,542 sh @ $89
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Feb 13, 2024

Hoge Stephen sold $26.2K of MRNA.

−$26.2K
304 sh @ $86
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Jan 17, 2024 ΔOwn −1.0%

Hoge Stephen sold $1.56M of MRNA, trimming their stake 1%.

−$1.56M
15,000 sh @ $104
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Dec 28, 2023 ΔOwn −2.9%

Hoge Stephen sold $4.5M of MRNA, trimming their stake 3%.

−$4.5M
45,000 sh @ $100
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Dec 5, 2023

Hoge Stephen sold $24.5K of MRNA.

−$24.5K
309 sh @ $79
MRNA
Sell Hoge Stephen · President · Open-market sale · filed Nov 30, 2023 ΔOwn −0.1%

Hoge Stephen sold $90.7K of MRNA.

−$90.7K
1,136 sh @ $80
MRNA
Option exercise Hoge Stephen · President · Option exercise · filed Nov 30, 2023 ΔOwn +0.2%
+$0
2,411 sh

Frequently asked questions

How is Hoge Stephen's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Hoge Stephen's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.